Oryzon Genomics SA
MAD:ORY

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
MAD:ORY
Watchlist
Price: 3.09 EUR -2.68% Market Closed
Market Cap: 246.9m EUR

Intrinsic Value

The intrinsic value of one ORY stock under the Base Case scenario is hidden EUR. Compared to the current market price of 3.09 EUR, Oryzon Genomics SA is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ORY Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Oryzon Genomics SA

Intrinsic Value History
Dive into the past to invest in the future

ORY looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ORY usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about ORY?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ORY valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Oryzon Genomics SA.

Explain Valuation
Compare ORY to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ORY?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Oryzon Genomics SA

Current Assets 37.3m
Cash & Short-Term Investments 34.4m
Receivables 2.8m
Other Current Assets 12.9k
Non-Current Assets 108.4m
Long-Term Investments 125.5k
PP&E 283.2k
Intangibles 104.3m
Other Non-Current Assets 3.7m
Current Liabilities 17.5m
Accounts Payable 2.6m
Accrued Liabilities 376.6k
Other Current Liabilities 14.5m
Non-Current Liabilities 11.5m
Long-Term Debt 4.1m
Other Non-Current Liabilities 7.4m
Efficiency

Free Cash Flow Analysis
Oryzon Genomics SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Oryzon Genomics SA

Revenue
0 EUR
Cost of Revenue
-1.2m EUR
Gross Profit
-1.2m EUR
Operating Expenses
-3.8m EUR
Operating Income
-5m EUR
Other Expenses
2.3m EUR
Net Income
-2.7m EUR
Fundamental Scores

ORY Profitability Score
Profitability Due Diligence

Oryzon Genomics SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
hidden
Profitability
Score

Oryzon Genomics SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ORY Solvency Score
Solvency Due Diligence

Oryzon Genomics SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
hidden
Solvency
Score

Oryzon Genomics SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ORY Price Targets Summary
Oryzon Genomics SA

Wall Street analysts forecast ORY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORY is 7.5 EUR with a low forecast of 4.04 EUR and a high forecast of 12.6 EUR.

Lowest
Price Target
4.04 EUR
31% Upside
Average
Price Target
7.5 EUR
143% Upside
Highest
Price Target
12.6 EUR
308% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Oryzon Genomics SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ORY is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ORY stock?

The intrinsic value of one ORY stock under the Base Case scenario is hidden EUR.

Is ORY stock undervalued or overvalued?

Compared to the current market price of 3.09 EUR, Oryzon Genomics SA is hidden .

Back to Top